Predictive machine learning models for survival outcomes in patients with pancreatic cancer.

被引：1
|
作者：
Shen, Yang-Chen
Chen, Po-See
Lin, Cheng-Feng
Liu, Ping-Yen
Lin, Peng-Chan
Yen, Chia-Jui
Shan, Yan-Shen
机构：
[1] Natl Cheng Kung Univ, Inst Behav Med, Coll Med, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Dept Phys Therapy, Tainan, Taiwan
[3] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan, Taiwan
[4] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Oncol, Tainan, Taiwan
[5] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Surg, Tainan, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
283-237-267; 227-149-9863-9995; 613-135-2370; 4; 2;
D O I：
10.1200/JCO.2024.42.3_suppl.625
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：625 / 625
页数：1
相关论文
共 50 条
  • [31] Effect of molecular genotyping to predict outcomes in patients with metastatic pancreatic cancer.
    Faris, Jason Edward
    Borger, Darrell R.
    Castillo, Carlos Fernandez-del
    Clark, Jeffrey W.
    Blaszkowsky, Lawrence Scott
    Zhu, Andrew X.
    Allen, Jill N.
    Murphy, Janet E.
    Ferrone, Cristina
    Goyal, Lipika
    Bardeesy, Nabeel
    Duda, Gabriel Dan
    Zheng, Hui
    Ting, David Tsai
    Kwak, Eunice Lee
    Lillemoe, Keith D.
    Wo, Jennifer Yon-Li
    Iafrate, A. John
    Ryan, David P.
    Hong, Theodore S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] SYMPTOM CLUSTERS AND CLINICAL OUTCOMES IN PATIENTS UNDERGOING SURGERY FOR PANCREATIC CANCER.
    Burrell, Sherry A.
    Yeo, Theresa P.
    Smeltzer, Suzanne
    Leiby, Benjamin E.
    Lavu, Harish
    Yeo, Charles J.
    ONCOLOGY NURSING FORUM, 2016, 43 (02) : E86 - E86
  • [33] Combination chemotherapy improves survival in pancreatic cancer.
    Buchler, P
    Hines, OJ
    Buchler, M
    Eibl, G
    Wente, MN
    Friess, H
    Isacoff, WH
    Reber, HA
    GASTROENTEROLOGY, 2002, 123 (01) : 16 - 16
  • [34] Survival after surgical treatment of pancreatic cancer.
    Z'graggen, K
    Wagner, M
    Friess, H
    Schilling, MK
    Maurer, CA
    Seiler, CA
    Buechler, MW
    GASTROENTEROLOGY, 2000, 118 (04) : A1538 - A1538
  • [35] ABO blood group and survival in pancreatic cancer.
    Wai, Christina
    Devarajan, Karthik
    Hoffman, John Parker
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [36] Machine learning models for predicting survival in patients with ampullary adenocarcinoma
    Huang, Tao
    Huang, Liying
    Yang, Rui
    Li, Shuna
    He, Ningxia
    Feng, Aozi
    Li, Li
    Lyu, Jun
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2022, 9 (12)
  • [37] Development of machine learning predictive models and risk scoring system for survival in breast cancer patients with type II diabetes: a retrospective cohort study
    Zhong, Claire Chenwen
    Huang, Junjie
    Li, Zhaojun
    Jiang, Yu
    Yang, Zehuan
    Huang, Ziwei
    Dou, Qi
    Li, Yu
    Wong, Martin C. S.
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2025, 55 : 112 - 112
  • [38] Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma
    He, C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [39] Machine learning models for predicting post-cystectomy recurrence and survival in bladder cancer patients
    Hasnain, Zaki
    Mason, Jeremy
    Gill, Karanvir
    Miranda, Gus
    Gill, Inderbir S.
    Kuhn, Peter
    Newton, Paul K.
    PLOS ONE, 2019, 14 (02):
  • [40] Impact of social determinants of health on a late diagnosis and survival of patients with pancreatic cancer.
    Fabregas, Jesus C.
    Lam, Miranda
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345